Purpose We conducted a systematic review and meta-analysis to measure the extent to
which race is associated with delayed initiation or receipt of inadequate chemotherapy …

Purpose Black women with breast cancer are known to have poorer survival than white
women. Suboptimal treatment may compromise the survival benefits of adjuvant …

Recent breast cancer treatment studies conducted in large urban settings have reported
racial disparities in the appropriate use of adjuvant chemotherapy. This article presents the …

Background Black patients with breast cancer may be at greater risk for chemotherapy-
related hematologic toxicity than white patients because of lower baseline blood cell counts …

While large differences by race/ethnicity in breast cancer survival are well established, it is
unknown whether differences in quality of chemotherapy delivered explain the racial/ethnic …

Objective. To examine racial disparities associated with breast cancer treatment and survival
in elderly patients with early stage operable breast cancer. Methods. We studied 23,110 …

Background The association between black race and worse outcomes in operable breast
cancer reported in previous studies has been attributed to a higher incidence of more …

Background Black race is associated with worse outcome in patients with breast cancer. The
distant relapse‐free survival (DRFS) between Black and White women with localized breast …

BACKGROUND: Racial disparities in breast cancer outcomes are attributed to differences in
baseline tumour characteristics and biology, stage, age, ethnic background and …

Purpose There are a paucity of data and a pressing need to evaluate response to
neoadjuvant chemotherapy (NACT) and determine long-term outcomes in young Black …